Next Article in Journal / Special Issue
Iron and Acinetobacter baumannii Biofilm Formation
Previous Article in Journal
Wild Mushroom Extracts as Inhibitors of Bacterial Biofilm Formation
Previous Article in Special Issue
Biomolecular Mechanisms of Pseudomonas aeruginosa and Escherichia coli Biofilm Formation
Article Menu

Export Article

Open AccessReview
Pathogens 2014, 3(3), 680-703; doi:10.3390/pathogens3030680

Pseudomonas aeruginosa Diversification during Infection Development in Cystic Fibrosis Lungs—A Review

CEB—Centre of Biological Engineering, LIBRO—Laboratório de Investigação em Biofilmes Rosário Oliveira, University of Minho, Campus de Gualtar, 4710-057 Braga, Portugal
*
Author to whom correspondence should be addressed.
Received: 1 July 2014 / Revised: 11 August 2014 / Accepted: 12 August 2014 / Published: 18 August 2014
(This article belongs to the Special Issue Biofilm-Based Nosocomial Infections)
View Full-Text   |   Download PDF [442 KB, uploaded 19 August 2014]   |  

Abstract

Pseudomonas aeruginosa is the most prevalent pathogen of cystic fibrosis (CF) lung disease. Its long persistence in CF airways is associated with sophisticated mechanisms of adaptation, including biofilm formation, resistance to antibiotics, hypermutability and customized pathogenicity in which virulence factors are expressed according the infection stage. CF adaptation is triggered by high selective pressure of inflamed CF lungs and by antibiotic treatments. Bacteria undergo genetic, phenotypic, and physiological variations that are fastened by the repeating interplay of mutation and selection. During CF infection development, P. aeruginosa gradually shifts from an acute virulent pathogen of early infection to a host-adapted pathogen of chronic infection. This paper reviews the most common changes undergone by P. aeruginosa at each stage of infection development in CF lungs. The comprehensive understanding of the adaptation process of P. aeruginosa may help to design more effective antimicrobial treatments and to identify new targets for future drugs to prevent the progression of infection to chronic stages. View Full-Text
Keywords: Pseudomonas aeruginosa; cystic fibrosis; clonal diversification; phenotypic variation; mucoid phenotype Pseudomonas aeruginosa; cystic fibrosis; clonal diversification; phenotypic variation; mucoid phenotype
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Sousa, A.M.; Pereira, M.O. Pseudomonas aeruginosa Diversification during Infection Development in Cystic Fibrosis Lungs—A Review. Pathogens 2014, 3, 680-703.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Pathogens EISSN 2076-0817 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top